QUAZX | VSGAX | QUAZX / VSGAX | |
Total Expense Ratio | 0.77 | 0.07 | 1,100% |
Annual Report Gross Expense Ratio | 0.78 | 0.07 | 1,114% |
Fund Existence | 10 years | 14 years | - |
Gain YTD | -1.759 | -1.038 | 169% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 3000 | 66,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.04B | 35B | 9% |
Annual Yield % from dividends | 0.00 | 0.54 | - |
Returns for 1 year | 10.23 | 11.79 | 87% |
Returns for 3 years | 36.51 | 39.54 | 92% |
Returns for 5 years | 8.63 | 38.43 | 22% |
Returns for 10 years | 40.33 | 112.31 | 36% |
1 Day | |||
---|---|---|---|
STOCK / NAME | Price $ | Chg $ | Chg % |
CNTB | 1.06 | 0.08 | +8.16% |
Connect Biopharma Holdings Limited | |||
CDLR | 20.84 | 0.97 | +4.88% |
Cadeler A/S American Depositary Share (each representing four (4) | |||
SIGIP | 16.78 | 0.12 | +0.72% |
Selective Insurance Group | |||
DSGX | 102.04 | 0.39 | +0.38% |
Descartes Systems Group | |||
FULC | 6.84 | -0.04 | -0.58% |
Fulcrum Therapeutics |